Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

To investigate the association of liver metabolite trimethylamine N-oxide (TMAO) with cardiovascular disease (CV)-related and all-cause mortality in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention. Our prospective observational study enrolled 292 patients...

Full description

Bibliographic Details
Main Authors: Ceren Eyileten, Joanna Jarosz-Popek, Daniel Jakubik, Aleksandra Gasecka, Marta Wolska, Marcin Ufnal, Marek Postula, Aurel Toma, Irene M. Lang, Jolanta M. Siller-Matula
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
trimethylamine N-oxide
acute coronary syndrome
type 2 diabetes mellitus
cardiovascular mortality
cardiovascular disease
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.728724/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.728724/full

Similar Items